Geron | GERN - ДОЛГ





ДОЛГ Изменить Дата
Amgen USD 54.6B 17M 2025-12
Bio Techne USD 200M 60M 2026-03
Cassava Sciences USD 0 0 2024-12
Cytokinetics USD 1.29B 4.48M 2026-03
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Exelixis USD 169.54M 3.5M 2026-03
Genmab DKK 148M 5M 2025-06
Geron USD 121.99M 76K 2025-12
Gilead Sciences USD 24.94B 5M 2025-12
Incyte USD 39.43M 982K 2026-03
MacroGenics USD 36.51M 500K 2026-03
Novartis USD 47B 11.62B 2026-03
Novavax USD 233.31M 4.23M 2024-09